Business Context and Reporting Period
Pediatrix Medical Group, Inc. filed its Form 10-Q for the quarterly period ended June 30, 2000. The Company operates as a national group practice providing pediatric medical services. As of August 10, 2000, there were 15,778,562 shares of common stock outstanding.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2000 | Six Months Ended June 30, 2000 |
|---|---|---|
| Net Patient Service Revenue | $55.2 million | $114.6 million |
| Income from Operations | $0.8 million | $7.9 million |
| Net (Loss) Income | $(0.3) million | $3.1 million |
| Diluted EPS | $(0.02) | $0.20 |
| Cash and Cash Equivalents | $1.2 million (Balance Sheet) | $1.2 million (Balance Sheet) |
| Net Cash Provided by Operating Activities | N/A | $10.5 million |
| Line of Credit Outstanding | $47.7 million | $47.7 million |
| Working Capital | Deficit of ~$15 million | Deficit of ~$15 million |
Material Changes vs. Prior Period
- Revenue: Reported revenue for the three months ended June 30, 2000, decreased to $55.2 million from $56.8 million in the prior year. This decline was driven by a $6.5 million charge to increase the allowance for contractual adjustments and uncollectible accounts. Excluding this charge, revenue increased by $4.9 million.
- Profitability: Net income turned to a loss of $0.3 million for the quarter compared to $7.8 million in the prior year. Income from operations dropped 93.8% to $0.8 million. Excluding the $6.5 million charge, net income would have been $3.4 million, still a 56.4% decrease year-over-year.
- Expenses: Salaries and benefits increased 25.2% to $44.2 million, primarily due to hiring new physicians for unit growth. Supplies and other operating expenses rose 31.5% due to new outpatient offices and legal fees related to government investigations.
- Cash Flow: Net cash provided by operating activities increased to $10.5 million for the six-month period compared to $9.5 million in the prior year. However, investing activities consumed $10.2 million, largely due to $8.1 million in payments for physician group acquisitions.
Guidance, Outlook, Risks, and Contingencies
- Collection Rates: Management cited a decline in collection rates due to increased utilization of non-critical care codes, reimbursement difficulties, and delays in receivables under appeal. Disruption in collection offices due to government investigations was also noted.
- Liquidity: The Company has a working capital deficit of approximately $15 million, primarily due to the classification of its line of credit as current. The $75 million line of credit matures on September 30, 2000, with $27.3 million available. The Company is evaluating financing options but noted no assurance of obtaining similar terms.
- Legal Proceedings:
- Securities Class Action: A consolidated federal securities class action regarding accounting practices and billing inquiries remains pending. The Company's motion to dismiss was denied in June 2000, and discovery has commenced.
- State Investigations: A settlement of $40,000 was reached with the Florida Attorney General regarding Medicaid billing, with no fraud found. Investigations in Arizona and Colorado remain ongoing, with potential material adverse effects uncertain.
- Acquisitions: The Company acquired three physician groups in the first six months of 2000 for approximately $8.1 million in cash.
Investor Verification Checklist
- Verify the status and potential financial impact of the ongoing state investigations in Arizona and Colorado.
- Confirm the Company's ability to refinance or extend its $75 million line of credit maturing September 30, 2000.
- Assess the sustainability of the $6.5 million revenue charge and future collection rate trends.
- Review the progress of the federal securities class action litigation and associated legal costs.
- Monitor the integration and performance of the three physician groups acquired in early 2000.